Tagrisso (osimertinib) - AstraZeneca
Kadcyla (ado-trastuzumab emtansine) - Roche
Vitrakvi (larotrectinib) - Bayer
relatlimab (BMS-986016) - BMS
Erivedge (vismodegib) - Roche
Paletan (pertuzumab biosimilar) - Sino Biopharm
omipalisib (GSK2126458) - GSK
Poherdy (pertuzumab-dpzb) - Organon, Shanghai Henlius Biotech
ABP 206 (nivolumab biosimilar) - Amgen
sapanisertib (CB-228) - Calithera
Trazimera (trastuzumab-qyyp) - Pfizer
Pertuvia (pertuzumab biosimilar) - Biocad
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Xalkori (crizotinib) - Pfizer
Tafinlar (dabrafenib) - Novartis
Hervelous (trastuzumab biosimilar) - Hanwha Solutions, Alvogen, Prestige BioPharma, Mundipharma, Dr. Reddy’s, Teva, Biosidus
Fakzynja (defactinib) - Verastem
Ibrance (palbociclib) - Pfizer
Balversa (erdafitinib) - J&J
fexagratinib (ABSK091) - Abbisko
Nivocad (nivolumab biosimilar) - Biocad
adavosertib (AZD1775) - AstraZeneca
Herceptin (trastuzumab) - Roche
Mektovi (binimetinib) - Pfizer
GSK2636771 - GSK
Truqap (capivasertib) - AstraZeneca
ulixertinib (BVD-523) - BioMed Valley Discoveries
Aliqopa (copanlisib) - Bayer
ipatasertib (RG7440) - Roche
dasatinib - Generic mfg.
taselisib (GDC-0032) - Roche
sunitinib - Generic mfg.
Mekinist (trametinib) - Novartis, BeOne Medicines
Gilotrif (afatinib) - Boehringer Ingelheim
http://clinicaltrials.gov/ct2/show/NCT02465060
 
Sep 30, 2026
 
Prev Next